This researcher is pushing for better data on gene expression in children
Deanne Taylor is spearheading efforts to create the first comprehensive database of healthy pediatric tissue, mapping gene expression in children to address a critical gap in medical research.
Intelligence analysis by Gemini 2.5 Flash
Medical research has historically overlooked children, often treating them as small adults, despite significant differences in gene expression. Deanne Taylor, a bioinformatics director, is leading the charge to build a foundational database of pediatric gene expression, crucial for understanding childhood development, disease, and drug responses.
Imagine your body has a giant instruction book, called DNA, that tells all your cells what to do. But just like a recipe book, not all recipes are used all the time, and some are changed as you grow up. This project is like making a special instruction book just for kids, showing exactly which 'recipes' (genes) are turned on or off, or turned up or down, at different ages. This helps doctors understand why kids get sick differently than grown-ups and how to give them the right medicine without causing harm.
Analysis
Deanne Taylor
Deanne Taylor's career path, which she describes as a "random walk," has been consistently driven by a profound curiosity about how things work and why illnesses manifest differently in individuals. Her early fascination with medical texts and physics led her to a PhD in biophysics, but the Human Genome Project inspired a shift towards bioinformatics. At Pfizer, she developed code for complex data in rare-disease research, and later contributed to pioneering computer programs for screening embryos for chromosomal abnormalities, many of which are still in use today. This diverse background uniquely positioned her to recognize and address the critical data gap in pediatric medicine.
Upon joining the Children’s Hospital of Philadelphia (CHOP) as director of bioinformatics, Taylor observed a significant lack of investment in research focused on children. She challenged the prevailing notion that children are merely small adults, emphasizing that their cells express genes differently, leading to varied and potentially dangerous responses to treatments. Her personal intensity, which she attributes to undiagnosed autism and ADHD, fueled her dedication to this overlooked area, culminating in her pivotal role in advocating for and establishing comprehensive pediatric gene expression data.
Human Cell Atlas
The Human Cell Atlas, an ambitious global project launched in 2017, initially aimed to map every cell in the human body but overlooked pediatric data. Deanne Taylor's alarm bells rang upon realizing this omission, prompting her to channel her concern into a focused campaign. She joined the project's volunteer team, contributing to a white paper that outlined the necessity of including children in the atlas's goals and plans. This intervention was a crucial step in broadening the scope of the Human Cell Atlas.
Taylor then rallied a coalition of pediatric researchers from various hospitals to contribute to the project, underscoring the collaborative spirit required for such a monumental undertaking. Her efforts culminated in a 2019 paper that formally articulated the case for studying children, a strategic move to attract greater interest and secure essential funding for pediatric research. This advocacy successfully put a "flag in the ground," as Taylor described it, highlighting the urgent need for healthy models of children's development within the broader Human Cell Atlas initiative. Thanks to her persistence and the work of her coauthors, the Human Cell Atlas now includes a dedicated pediatric section, ensuring that children's unique biological profiles are not ignored.
dGTEx Project
The Developmental Genotype-Tissue Expression Project (dGTEx) represents a significant advancement in pediatric research, directly benefiting from Deanne Taylor's advocacy. In 2021, the NIH awarded a substantial $38.5 million grant to dGTEx, establishing it as the first comprehensive database of healthy pediatric tissue. This project meticulously collects samples from otherwise healthy children who have died, with parental consent for body donation, and then maps how genes are expressed across all major organ systems.
Taylor and her team are responsible for curating and standardizing the vast amount of information associated with each tissue donation, including family history and detailed sample specifics. A separate group conducts the actual analysis of the samples, with all data subsequently combined to form a robust database. This baseline of pediatric gene expression is foundational, enabling future research into normal development, disease mechanisms, and the effectiveness of drugs in children. The dGTEx data will eventually be integrated into the Human Cell Atlas, further enriching the global understanding of human biology across the lifespan. This project is critical because gene expression changes significantly during development, influencing how therapies work and potentially causing adverse effects, such as chemotherapy damaging children's developing hearts due to unique cardiac gene expression patterns.
Key points
- Deanne Taylor is leading efforts to create the first comprehensive database of healthy pediatric tissue.
- Children's cells express genes differently than adults', impacting disease and drug responses.
- The dGTEx project, funded by a $38.5 million NIH grant, collects and maps gene expression in deceased healthy children.
- This data will feed into the Human Cell Atlas, which now includes a pediatric section thanks to Taylor's advocacy.
- The initiative aims to establish a baseline for pediatric gene expression, crucial for advancing knowledge of development, disease, and drug effectiveness.
This research promises to revolutionize pediatric medicine by providing a foundational understanding of childhood development and disease at a molecular level. It could lead to safer, more effective treatments tailored specifically for children, preventing lifelong health issues and improving outcomes for countless young patients.
Despite the significant funding, the immense complexity of mapping gene expression across all organ systems in children presents substantial challenges. Data collection relies on sensitive donations, and the sheer volume and variability of biological data mean that fully understanding and applying this knowledge will be a long and arduous scientific journey.
